KEBOMED A/S: Financial statements 2018
CVR: 28490704
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
KEBOMED A/S (CVR 28490704) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 41,213,010 and a net result of DKK 11,571,385 compared with DKK 6,761,301 the year before. That is an increase of 0.7% compared with the year before. Equity in the 2018 report amounted to DKK 12,632,776. The solvency ratio was 21.3%.
- Gross Profit
- DKK 41,213,010
- Profit/Loss
- DKK 11,571,385
- Equity
- DKK 12,632,776
- Total Assets
- DKK 59,307,411
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 41.2M | 11.6M | 12.6M | - |
| 2017 | - | 40.9M | 6.8M | 16.8M | - |
| 2016 | - | 37.7M | 9M | 10M | - |
| 2015 | - | 38.9M | 9.8M | 6.9M | - |
| 2014 | - | 54.2M | 13.7M | 14.7M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout KEBOMED A/S
KEBOMED A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2005. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named KEBO MED A/S. The management consists of Henrik Schjødt. The board consists of Niels Søren Frederik Kornerup (chair), Henrik Schjødt and Søren Dalmark Kornerup. The company is owned by Kebomed Europe Holding AG. The company has 23 employees (2026). In 2026, the company reported a gross profit of DKK 52,977,983 and a net result of DKK 13,110,236 compared with DKK 9,827,524 the year before. Equity in the 2026 report amounted to DKK 36,352,192.